Fitlife Brands, Inc.
FTLF- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001374328
In the last 90 days, Fitlife Brands, Inc. insiders filed 1 open-market purchase and 0 sales; 42 institutions reported holding it in 13F filings for Q2 2026, worth $7.08M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Fitlife Brands, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 2 | 10 | +8 |
| Shares | 77.3K | 103.2K | +25.9K (+33.5%) |
| Value | $1.41M | $1.97M | +$555.3K (+39.3%) |
New holders (8)
Institutions that held Fitlife Brands, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 12,848 | $243.1K | 0.00% |
| Geode Capital Management, LLC | 10,331 | $195.5K | 0.00% |
| Advisor Group Holdings, Inc. | 1,600 | $30.6K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,001 | $19.1K | 0.00% |
| Tennessee Valley Asset Management Partners | 100 | $1.91K | 0.00% |
| Wells Fargo & Company | 14 | $267 | 0.00% |
| JPMorgan Chase & Co | 3 | $57 | 0.00% |
| Bank of America Corp | 1 | $19 | 0.00% |
Sold out (0)
Institutions that held Fitlife Brands, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
None.